Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A serum-specific biomarker for diagnosing primary liver cancer and its screening method and application

A biomarker and primary liver cancer technology, applied in biochemical equipment and methods, microbiological determination/testing, DNA/RNA fragments, etc., can solve problems such as failure to elucidate the mechanism of HCC metastasis and recurrence, and achieve diagnostic value Improvement, high sensitivity and specificity, effect of enhanced sensitivity and specificity

Active Publication Date: 2021-11-02
WENZHOU MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Although some progress has been made in the basic and clinical research of HCC in recent years, the mechanism of HCC metastasis and recurrence has not yet been elucidated.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A serum-specific biomarker for diagnosing primary liver cancer and its screening method and application
  • A serum-specific biomarker for diagnosing primary liver cancer and its screening method and application
  • A serum-specific biomarker for diagnosing primary liver cancer and its screening method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] The present invention will now be further described in conjunction with specific content, and the present invention will be further described below in conjunction with specific embodiments. These examples are only for illustrating the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the contents of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

[0041] The experimental methods in the following examples are conventional methods unless otherwise specified.

[0042] The materials and reagents used in the following examples can be obtained from commercial sources unless otherwise specified.

[0043] Materials and methods

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
Login to View More

Abstract

A serum-specific biomarker for the diagnosis of primary liver cancer and its screening method and application, using the Boyden chamber to separate the protrusion and cell body of liver cancer metastatic cells, starting from the subcellular structure, using the improved Boyden chamber method to separate liver cancer metastatic cells For cell bodies and protrusions, the separation results were verified by Western-blot, RNA staining, immunofluorescence and other techniques. Study the differential expression in HCCLM3 liver cancer cell body and protrusion, and screen out microRNAs related to the invasion and metastasis of HCC. Clinical experiments have proved that the change of individual serum hsa-let-7c-3p has a higher diagnostic value for HCC. Sensitivity and specificity. The present invention will provide a new diagnostic method for clinical diagnosis of primary liver cancer, and has certain potential clinical value in assisting the treatment of HCC and monitoring the course of disease, through the ROC curve of let-7c-3p, and let-7c-3p The ROC curves of combined use with CEA, let-7c-3p with AFP, and let-7c-3p with AFP and CEA have improved sensitivity and specificity, and the diagnostic value has been significantly improved.

Description

technical field [0001] The present invention specifically relates to the field of molecular biology technology, in particular to a serum-specific biomarker for diagnosing primary liver cancer, a screening method and application. Background technique [0002] Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor worldwide. Although great progress has been made in the diagnosis and treatment of HCC in recent years, the 5-year survival rate of HCC patients is still quite low due to the frequent clinical recurrence and metastasis of HCC. The occurrence and development of HCC is a typical multi-stage process: first, liver tissue is exposed to external stimuli (hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, aflatoxin B1 intake or alcohol abuse etc.) develop chronic hepatitis or cirrhosis, and then, after going through a series of hyperplasia and dysplasia stages, finally acquire the malignant phenotype of intrahepatic metastasis and distant metast...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886C12N15/11C12Q1/6806
CPCC12Q1/6806C12Q1/6886C12Q2600/158C12Q2600/178
Inventor 季敬璋申志发冯笑金玉龚莉莎胡雪梅
Owner WENZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products